Latest news with #Soybean
Bloomberg
4 days ago
- Business
- Bloomberg
Soy Touches Five-Week High After USDA's Surprise Cut to US Acres
Soybean futures jumped to the highest intraday level since July 3, with the US Department of Agriculture's surprisingly large supply cut in the previous session helping to shake up the market. Demand for the oilseed remains uncertain as the world's top importer China continues to avoid American crops, but the supply side is tighter thanks to the USDA's chop to planted acres. With a smaller area, overall US stockpiles for the upcoming 2025-26 season are forecast to fall to the lowest in about three years.
Bloomberg
6 days ago
- Business
- Bloomberg
Soybean Futures Fall After Trump Extends Trade Truce With China
Soybean prices fell back below $10 a bushel, as traders saw news of an extended US-China trade truce as likely delaying major grain-purchasing deals between the nations until late this year. Contracts for a November delivery had dropped about 1% as of 11:45 a.m. Singapore time, a turnaround from Monday's 2.4% rise that came in response to US President Donald Trump's call for China to 'quadruple' its purchases of the major oilseed.
Yahoo
06-08-2025
- Business
- Yahoo
Soybeans Resuming Losses on Wednesday
Soybean futures are heading lower on Wednesday, with losses of 7 to 8 ½ cents. CME reported preliminary open interest up 4,577 contracts on Tuesday. The cmdtyView national average Cash Bean price is down 8 1/2 cents at $9.25 3/4. Soymeal futures are heading back lower, down $5.10 to $6.30. Soy Oil futures are back up 10 to 31 points. There were 518 delivery notices for August soybean meal overnight, with none issued for soybeans and soybean oil. Temps are expected to warm up for a good portion of the central and eastern corn belt through the weekend. Precip is seen as limited through Frida, with some forecast for ND an scattered totals in IA and WI. The early part of next week is showing 1 to 2 inch totals expected for southern NE, IA, northern MO, and WI. More News from Barchart Arabica Coffee Prices Sharply Higher on Brazil Coffee Crop Concerns Arabica Coffee Supported by Dry Conditions in Brazil Can Sugar Break Out from Its Bearish Trend? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Following threats of increased tariffs if India doesn't stop purchasing Russian oil, President Trump is set to raise tariffs by 25% to 50% on India starting on August 27 if they continue to import Russian oil. Aug 25 Soybeans are at $9.62, down 7 cents, Nearby Cash is at $9.25 3/4, down 8 1/2 cents, Sep 25 Soybeans are at $9.62 3/4, down 8 3/4 cents, Nov 25 Soybeans are at $9.82 1/4, down 8 1/2 cents, New Crop Cash is at $9.14 3/4, down 8 3/4 cents, On the date of publication, Austin Schroeder did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-07-2025
- Business
- Yahoo
Some Soybeans Climb Back into Plus Territory Tuesday Morning
Soybean prices are mixed at midday on Tuesday, with nearby August down around 2 cents as this is written, while new crop contracts (November and later) are up 1 cent or more per bushel from the Monday settlement. Bean prices were under pressure on Monday, and were down 9 to 13 cents at the close. Preliminary open interest was up 1,685 contracts on Monday, suggesting new selling interest. The cmdtyView national average new crop Cash Bean price is up ½ cent today at $9.77 3/4. Soymeal futures are up $2.10 to $2.50/ton. Renewable diesel input Soy Oil is suffering from weakness in the energy markets, down 25 to 30 points. August crude is down almost $1 per barrel at midday. The Monday afternoon Crop Progress report from USDA showed 62% of the US bean crop blooming, with 26% setting pods. Condition ratings slipped 2% from the previous week to 68% in the good/excellent categories, as the broader Brugler500 index was down 2 points to 373. Iowa was rated 80% good or excellent, while the states east of the Mississippi River are at 60% or below. The national decline for the week was primarily in ND and KS, with Ohio and SD improving the most. More News from Barchart Brazil Coffee Harvest Pressures Slam Coffee Prices Brazil Coffee Harvest Pressures Hammer Prices Cocoa Prices Rally as the Pace of Ivory Coast Cocoa Exports Slows Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! USDA reported soybean export inspections for the week ending July 17 totaled 364,990 metric tonnes (MT), up modestly from 338,255 MT a year ago and sharply higher than the 151.346 MT reported last week (after today's revisions). Aug 25 Soybeans are at $10.13 1/4, down 1 3/4 cents, Nearby Cash is at $9.76, down 1 cents, Sep 25 Soybeans are at $10.09 1/2, down 1 cent, Jan 26 Soybeans are at $10.44 1/2, up 3/4 cent, New Crop Cash is at $9.77 1/2, up 1/4 cent, On the date of publication, Austin Schroeder did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-03-2025
- Business
- Yahoo
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights
Cash and Cash Equivalents: $14.4 million as of December 31, 2024. R&D Expense: $12.4 million for Q4 2024, down from $14.2 million in the prior year. SG&A Expenses: $6.8 million for Q4 2024, unchanged from the prior year. Net Loss: $25.8 million for Q4 2024, compared to $277.2 million in the prior year, which included a $249 million non-cash goodwill impairment charge. Net Proceeds from Offering: $21.6 million received in 2025. Warning! GuruFocus has detected 7 Warning Signs with CBUS. Release Date: March 20, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Cibus Inc (NASDAQ:CBUS) is making significant progress in its transformation from an agricultural trait development company to a commercial trait company, with a focus on gene-edited productivity traits. The company's proprietary Rapid Trait Development System (RTDS) allows for precise gene editing, making traits indistinguishable from those developed via conventional breeding, which is advantageous from a regulatory perspective. Cibus Inc (NASDAQ:CBUS) has established collaborations with major rice seed companies in North and Latin America, representing approximately 40% of accessible rice acres in these regions. The company is seeing promising results from field trials, particularly in rice and canola, which are moving towards commercialization. Cibus Inc (NASDAQ:CBUS) is well-positioned to benefit from favorable regulatory changes in the EU, which could expand the market for gene-edited products. Cibus Inc (NASDAQ:CBUS) reported a net loss of $25.8 million for the fourth quarter of 2024, although this is an improvement from the previous year's loss. The company is reliant on existing cash and cash equivalents to fund operations into the late third quarter of 2025, highlighting potential financial constraints. There is uncertainty regarding the timing of commercialization for some of Cibus Inc (NASDAQ:CBUS)'s products, particularly in the EU market. The company is still in the process of developing its Soybean platform, which is crucial for accessing a substantial market. Cibus Inc (NASDAQ:CBUS) is facing challenges in achieving cost reductions, although some progress has been made in streamlining operations. Q: Could you explain what the recent EU decision means for Cibus in terms of milestones or timelines for commercial products in Europe? Also, how have changes in the regulatory landscape affected customer interest and potential revenue structures? A: The EU's progress on New Genomic Techniques (NGTs) is crucial for Cibus. The EU Council's recent actions allow for the final adoption of the text approved by the parliament, which impacts trade and cultivation globally. This regulatory clarity accelerates customer programs and enhances the path to market for gene-edited products. Cibus' non-GMO, conventional-like approach aligns well with these regulatory changes, facilitating clearer paths through grain trade and customer engagement. Q: How does the current draft of the EU law affect the patentability of genetic modifications, and what impact does this have on customer demand? A: The EU Council's stance on patenting emphasizes transparency, requiring seed companies to disclose patents behind their products. This strengthens intellectual property coverage, providing a robust framework for seed companies and enhancing customer confidence in adopting gene-edited traits. Q: Given the progress on various traits and products, has the timing for commercialization changed from last quarter? A: The commercialization timelines remain on track. Field trials for the HT2 trait and advancements in Sclerotinia resistance are progressing well. The favorable European regulatory environment is encouraging customers to expedite market entry, particularly for Canola and Winter Oilseed Rape programs. Q: Regarding the Sustainable Ingredients business, should we expect meaningful revenues in 2026 from bio-fragrance or partner-based projects? A: Cibus anticipates revenues from the bio-fragrance segment in 2026. Significant progress has been made in fermentation-based products, aligning with the demand from multinational CPG companies for sustainable ingredients. This development leverages Cibus' expertise in yeast genetics and fermentation. Q: Are there any priority traits and crops that Cibus intends to focus on for commercialization? A: Cibus is prioritizing its 3-crop Biotrait platform, focusing on Rice, Canola, and Winter Oilseed Rape. The company is also advancing its Soybean platform, particularly targeting Sclerotinia tolerance and disease resistance, which traditional breeding and GMO methods have not effectively addressed. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
